The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.

scientific article published on 24 February 2016

The Receptor-Binding Domain in the VP1u Region of Parvovirus B19. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/V8030061
P932PMC publication ID4810251
P698PubMed publication ID26927158
P5875ResearchGate publication ID295893918

P50authorCarlos RosQ88458880
P2093author name stringChristoph Kempf
Remo Leisi
Chiarina Di Tommaso
P2860cites workSusceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation.Q54330531
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapyQ69354191
Replication of the B19 parvovirus in human bone marrow cell culturesQ69580453
Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitroQ70186121
Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbitsQ71670097
Human parvovirus, the cause of erythema infectiosum (fifth disease)?Q72554009
Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthemQ78032180
Human parvovirus B19.Q24532891
Asymmetric binding of transferrin receptor to parvovirus capsidsQ24683829
Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force fieldQ28261756
The Jpred 3 secondary structure prediction serverQ29547592
The family ParvoviridaeQ33578983
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteinsQ33653001
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.Q33900233
Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragmentsQ33927991
Parvovirus-associated arthritisQ33979933
Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and reviewQ33982832
Pathogenesis of human parvovirus B19 in rheumatic diseaseQ34024904
Parvovirus-like particles in human seraQ34214388
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surfaceQ34222176
Parvovirus B19.Q34294811
Generation of a parvovirus B19 vaccine candidateQ34355555
Clinical presentations of parvovirus B19 infectionQ34575717
The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalizationQ34623255
Immune response to B19 parvovirus and an antibody defect in persistent viral infectionQ35815343
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regionsQ36646671
Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropismQ37336824
Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease processQ38226745
Specific Targeting of Proerythroblasts and Erythroleukemic Cells by the VP1u Region of Parvovirus B19.Q38846473
Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.Q39139995
Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1Q39305479
Characterization of the early steps of human parvovirus B19 infectionQ39327644
Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancementQ40358470
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infectionQ40389867
Visualization of the externalized VP2 N termini of infectious human parvovirus B19.Q41337979
Parvovirus B19 VLP recognizes globoside in supported lipid bilayers.Q42212619
The VP1-unique region of parvovirus B19: amino acid variability and antigenic stabilityQ43465663
Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entryQ44542238
Erythrocyte P antigen: cellular receptor for B19 parvovirusQ45873217
His-tags as Zn(II) binding motifs in a protein-based fluorescent sensorQ46575857
Site-specific cross-linking of proteins through tyrosine hexahistidine tagsQ46803340
Severe digital arterial occlusive disease and acute parvovirus B19 infectionQ48547968
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)61
P577publication date2016-02-24
P1433published inVirusesQ7935305
P1476titleThe Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
P478volume8

Reverse relations

cites work (P2860)
Q92026959Advances in the Development of Antiviral Strategies against Parvovirus B19
Q47727907Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome
Q48244049Genetic analysis of three porcine bocaparvoviruses and identification of a natural recombinant breakpoint in NS1.
Q92152922Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection
Q38996997Human Parvoviruses
Q89985874Inflammatory dilated cardiomyopathy : Etiology and clinical management
Q55236939Recent Advances in Replication and Infection of Human Parvovirus B19.
Q37378794The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.

Search more.